New $5 million competition announced for developing rapid COVID-19 testing
Xprize has unveiled a new $5 million competition to encourage the development of rapid COVID-19 testing.
The non-profit organization on Tuesday announced the Xprize Rapid COVID Testing competition to "accelerate the development of high-quality COVID-19 testing that is low cost, easy to use, and fast-turnaround, enabling frequent testing." Xprize and OpenCovidScreen are asking the "world's brightest, most innovative minds" to get involved and develop new fast and affordable testing solutions that might help facilitate a safe return to school and work amid the pandemic, as other COVID-19 testing methods can take days to produce a result.
The submissions, Xprize says, can be in one of four categories including at-home and point-of-care testing, and entries will be judged on factors like innovation, performance, turnaround time, and cost. Five teams will ultimately be awarded $1 million each, and the maximum turnaround time is 12 hours, TechCrunch reports.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Fast, affordable, and accessible testing is crucial to containing the COVID-19 pandemic and safely reopening schools, businesses and other vital institutions around the world,” Xprize CEO Anousheh Ansari said in a statement. "Xprize Rapid COVID Testing is inspiring the best entrepreneurial and scientific teams to come together to work towards rapid, affordable COVID-19 testing at scale, and ultimately, getting the world up and running again."
Xprize is asking teams to register for the competition by the end of August.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
- 
Margaret Atwood’s ‘deliciously naughty’ memoirIn the Spotlight ‘Bean-spilling’ book by The Handmaid’s Tale author is ‘immensely readable’
 - 
Being a school crossing guard has become a deadly jobUnder the Radar At least 230 crossing guards have been hit by cars over the last decade
 - 
Crossword: November 4, 2025The Week's daily crossword
 
- 
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
 - 
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
 - 
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
 - 
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
 - 
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
 - 
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
 - 
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
 - 
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
 
